/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Inflammation as key driver of vascular dysfunction
Event: ESC Congress 2023
Topic: Vascular Biology and Physiology
Session type: Moderated ePosters
Improving the management of patients with atherosclerotic cardiovascular disease: the evolving role of icosapent ethyl
Event: ESC Congress 2023
Topic: Lipid-Lowering Agents
Session type: Satellite Symposium
Vascular disease and perturbed lipid metabolism
Event: ESC Congress 2023
Topic: Lipids, Metabolism
Session type: Moderated ePosters
Inflammation in atherosclerotic cardiovascular disease (ASCVD): the spark before the fire?
Event: ESC Congress 2022
Topic: Inflammation and Immunity
Session type: Satellite Symposium
The EHJ’s Year in Cardiovascular Medicine 2020: heart failure, valvular heart disease, imaging
Event: ESC Congress 2021 - The Digital Experience
Topic: Training and Education
Session type: Official Joint Session
Tackling residual risk beyond LDL-c therapy: The emerging role of EPA & triglycerides
Event: ESC Congress 2021 - The Digital Experience
Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)
Session type: Satellite Symposium
Novel opportunities tackling residual cardiovascular Risk: The evolving role of triglycerides
Event: ESC Congress 2020
Topic: Secondary Prevention
Session type: Industry Q&A session
New concepts and models in cardiovascular risk management (EBAC Accredited)
Event: ESC Congress 2018
Topic: Risk Factors and Prevention
Session type: Satellite Symposium
Emerging evidence-based approaches to reduce residual atherosclerotic risk - Ask the experts
Event: ESC Congress 2018
Topic: Risk Factors and Prevention
Session type: Satellite Symposium - Experts on the Spot
Atherosclerosis and secondary cardiovascular disease prevention: inflammation and low density lipoprotein (LDL)-cholesterol
Event: ESC Congress 2017
Topic: Atherosclerosis
Session type: Satellite Symposium
ESC 365 is supported by
